Long-term neurocognitive functioning after electroconvulsive therapy in patients with late-life depression
- PMID: 30003550
- DOI: 10.1111/acps.12942
Long-term neurocognitive functioning after electroconvulsive therapy in patients with late-life depression
Abstract
Objective: There is ongoing concern about the possible negative impact of ECT on neurocognitive functioning in older patients. In this study, we aimed to characterize the long-term cognitive effects of ECT in patients with late-life depression, using an extensive neuropsychological battery.
Methods: A total of 110 patients aged 55 years and older with unipolar depression, referred for ECT were included. The neuropsychological test battery was assessed prior to ECT and 6 months after the last ECT session.
Results: There were no statistically significant group-level changes from baseline to 6 months post-ECT in any of the neuropsychological measurements. Individual differences in cognitive performance were detected using the Reliable Change Index.
Conclusion: Patients with late-life depression do not show deleterious cognitive effects 6 months following an ECT index course, although there are considerable differences at an individual level. Clinicians should not hesitate to prescribe ECT in older patients, as most of these patients will tolerate the treatment course and a small group will even experience a cognitive enhancement. However, clinicians should be aware that a small group of patients can experience cognitive side-effects. Further study is needed to predict which patients have a higher risk of developing cognitive side-effects.
Keywords: ECT; cognitive side-effects; depression; individual differences; late-life depression.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
Thoughts About Electroconvulsive Therapy and New Potential Treatments for Treatment-Resistant Depression in the Elderly.Am J Geriatr Psychiatry. 2019 Sep;27(9):945-947. doi: 10.1016/j.jagp.2019.05.006. Epub 2019 May 10. Am J Geriatr Psychiatry. 2019. PMID: 31255468 No abstract available.
Similar articles
-
Neurocognitive functioning after electroconvulsive therapy in late-life depression: A 4-year prospective study.Acta Psychiatr Scand. 2021 Feb;143(2):141-150. doi: 10.1111/acps.13252. Epub 2020 Dec 31. Acta Psychiatr Scand. 2021. PMID: 33150605
-
Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.Int Psychogeriatr. 2014 Feb;26(2):315-24. doi: 10.1017/S1041610213001932. Epub 2013 Nov 26. Int Psychogeriatr. 2014. PMID: 24280446
-
Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.Trials. 2018 Apr 19;19(1):234. doi: 10.1186/s13063-018-2627-2. Trials. 2018. PMID: 29673379 Free PMC article.
-
Systematic Review of Cognitive Effects of Electroconvulsive Therapy in Late-Life Depression.Am J Geriatr Psychiatry. 2016 Jul;24(7):547-65. doi: 10.1016/j.jagp.2016.02.053. Epub 2016 Mar 8. Am J Geriatr Psychiatry. 2016. PMID: 27067067 Review.
-
The effects of ECT on cognitive functioning in the elderly: a review.Int J Geriatr Psychiatry. 2008 Aug;23(8):789-95. doi: 10.1002/gps.1989. Int J Geriatr Psychiatry. 2008. PMID: 18311845 Review.
Cited by
-
Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy.Wien Klin Wochenschr. 2024 Apr 17. doi: 10.1007/s00508-024-02358-w. Online ahead of print. Wien Klin Wochenschr. 2024. PMID: 38662240 Review.
-
Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study.Front Psychiatry. 2023 Feb 9;14:1026014. doi: 10.3389/fpsyt.2023.1026014. eCollection 2023. Front Psychiatry. 2023. PMID: 36846232 Free PMC article.
-
The Use of ECT in the Elderly-Looking Beyond Depression.Curr Psychiatry Rep. 2022 Sep;24(9):451-461. doi: 10.1007/s11920-022-01353-0. Epub 2022 Jul 13. Curr Psychiatry Rep. 2022. PMID: 35829850 Review.
-
Study of effect of nimodipine and acetaminophen on postictal symptoms in depressed patients after electroconvulsive therapy (SYNAPSE).Trials. 2022 Apr 18;23(1):324. doi: 10.1186/s13063-022-06206-y. Trials. 2022. PMID: 35436940 Free PMC article. Clinical Trial.
-
Cognitive Considerations in Major Depression: Evaluating the Effects of Pharmacotherapy and ECT on Mood and Executive Control Deficits.Brain Sci. 2022 Mar 4;12(3):350. doi: 10.3390/brainsci12030350. Brain Sci. 2022. PMID: 35326307 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
